Black, Hispanic patients less likely to receive paxlovid COVID-19 treatment than white patients

A new report finds stark differences along racial lines when it comes to getting treated for the coronavirus.

The CDC says black and Hispanic people were less likely to receive paxlovid and other COVID-19 treatments than white patients.

Paxlovid is a tablet used to treat COVID-19 in adults and children who are at least 12 years old.

The agency says one in three white patients was prescribed paxlovid for COVID-19, compared to one in five black and Hispanic patients.

Researchers say the disparities could be due to access, implicit bias among health providers, and distrust of the medical system.

Leave comment

Your email address will not be published. Required fields are marked with *.